Weiyun Ai, MD, PhD

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. (20697067)

Brody JD, Ai WZ, Czerwinski DK, Torchia JA, Levy M, Advani RH, Kim YH, Hoppe RT, Knox SJ, Shin LK, Wapnir I, Tibshirani RJ, Levy R PMID: 20697067

C-C chemokine receptor 1 expression in human hematolymphoid neoplasia. (20154287)

Anderson MW, Zhao S, Ai WZ, Tibshirani R, Levy R, Lossos IS, Natkunam Y PMID: 20154287

Left ventricular rupture due to HIV-associated T-cell lymphoma. (20844622)

Armstrong EJ, Bhave P, Wong D, Ursell PC, Kaplan L, Yeghiazarians Y, Ai WZ PMID: 20844622

Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma. (19346494)

Ai WZ, Tibshirani R, Taidi B, Czerwinski D, Levy R PMID: 19346494

[Analysis of clinical characteristics and treatment outcome of bilateral and unilateral sudden sensorineural hearing loss]. (19670609)

Ai W, Tong B, Liu Y, Duan M PMID: 19670609

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. (18814264)

Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R PMID: 18814264

''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. (17652637)

Weinberg OK, Ai WZ, Mariappan MR, Shum C, Levy R, Arber DA PMID: 17652637

Management of advanced stage Hodgkin lymphoma. (16507271)

Advani R, Ai WZ, Horning SJ PMID: 16507271